CollPlant Bio (CLGN) Revenue & Revenue Breakdown
CollPlant Bio Revenue Highlights
Latest Revenue (Y)
$10.96M
Latest Revenue (Q)
$98.00K
Main Geography (Y)
UNITED STATES
CollPlant Bio Revenue by Period
CollPlant Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $10.96M | 3565.22% |
| 2022-12-31 | $299.00K | -98.09% |
| 2021-12-31 | $15.64M | 154.86% |
| 2020-12-31 | $6.14M | 164.75% |
| 2019-12-31 | $2.32M | -51.59% |
| 2018-12-31 | $4.79M | 897.75% |
| 2017-12-31 | $479.92K | 532.21% |
| 2016-12-31 | $75.91K | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
CollPlant Bio generated $10.96M in revenue during NA 2023, up 3565.22% compared to the previous quarter, and up 228.87% compared to the same period a year ago.
CollPlant Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $98.00K | -67.22% |
| 2023-12-31 | $299.00K | 595.35% |
| 2023-09-30 | $43.00K | -99.58% |
| 2023-06-30 | $10.18M | 2251.96% |
| 2023-03-31 | $433.00K | 646.55% |
| 2022-12-31 | $58.00K | -46.79% |
| 2022-09-30 | $109.00K | 65.15% |
| 2022-06-30 | $66.00K | - |
| 2022-03-31 | $66.00K | -78.71% |
| 2021-12-31 | $310.00K | 121.43% |
| 2021-09-30 | $140.00K | -79.74% |
| 2021-06-30 | $691.00K | -95.23% |
| 2021-03-31 | $14.50M | 2503.23% |
| 2020-12-31 | $557.00K | -86.57% |
| 2020-09-30 | $4.15M | 404.01% |
| 2020-06-30 | $823.00K | 35.14% |
| 2020-03-31 | $609.00K | 38.72% |
| 2019-12-31 | $439.00K | -35.35% |
| 2019-09-30 | $679.00K | 12.05% |
| 2019-06-30 | $606.00K | 2.02% |
| 2019-03-31 | $594.00K | -85.83% |
| 2018-12-31 | $4.19M | 1762.86% |
| 2018-09-30 | $225.05K | 26.07% |
| 2018-06-30 | $178.50K | -19.53% |
| 2018-03-31 | $221.84K | -19.01% |
| 2017-12-31 | $273.91K | 267.61% |
| 2017-09-30 | $74.51K | 29.29% |
| 2017-06-30 | $57.63K | -17.14% |
| 2017-03-31 | $69.55K | 35.29% |
| 2016-12-31 | $51.41K | 109.79% |
| 2016-09-30 | $24.50K | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | - |
CollPlant Bio generated $98.00K in revenue during Q1 2024, up -67.22% compared to the previous quarter, and up 168.97% compared to the same period a year ago.
CollPlant Bio Revenue Breakdown
CollPlant Bio Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 18 |
|---|---|---|---|---|---|
| ISRAEL | $5.00K | - | - | - | - |
| CANADA | $87.00K | - | - | - | - |
| UNITED STATES | $10.84M | $174.00K | $15.01M | - | - |
| Europe | - | $125.00K | $628.00K | $369.00K | - |
| TotalMember | - | - | $15.64M | $6.14M | - |
| United States And Canada | - | - | - | - | $17.51M |
| Europe Country | - | - | - | - | $523.00K |
CollPlant Bio's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (99.16%), CANADA (0.80%), and ISRAEL (0.05%).
Quarterly Revenue by Country
| Country | Dec 21 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|
| Europe | $130.00K | $498.00K | $34.00K | $53.00K |
| TotalMember | $14.95M | $691.00K | - | - |
| UNITED STATES | $14.82M | $193.00K | - | - |
| United states and Canada | - | - | $789.00K | $553.00K |
CollPlant Bio's latest quarterly revenue breakdown by geography, as of Dec 21: TotalMember (50.00%), UNITED STATES (49.57%), and Europe (0.43%).
CollPlant Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VCEL | Vericel | $197.52M | $52.66M |
| MRUS | Merus | $43.95M | $7.33M |
| NAMS | NewAmsterdam Pharma Company | $14.09M | $1.40M |
| CLGN | CollPlant Bio | $10.96M | $98.00K |
| IKNA | Ikena Oncology | $9.16M | - |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| PRTC | PureTech Health | $3.33M | $178.57K |
| HCWB | HCW Biologics | $2.84M | $618.85K |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| MNOV | MediciNova | $1.00M | - |
| KROS | Keros Therapeutics | $151.00K | $83.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| XCUR | Exicure | - | - |
| CCCC | C4 Therapeutics | - | - |
| REPL | Replimune Group | - | - |
| CYT | Cyteir Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| PRLD | Prelude Therapeutics | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| ENOB | Renovaro Biosciences | - | - |
| CSBR | Champions Oncology | - | $12.02M |
CLGN Revenue FAQ
What is CollPlant Bio’s yearly revenue?
CollPlant Bio's yearly revenue for 2023 was $10.96M, representing an increase of 3565.22% compared to 2022. The company's yearly revenue for 2022 was $299K, representing a decrease of -98.09% compared to 2021. CLGN's yearly revenue for 2021 was $15.64M, representing an increase of 154.86% compared to 2020.
What is CollPlant Bio’s quarterly revenue?
CollPlant Bio's quarterly revenue for Q1 2024 was $98K, a -67.22% decrease from the previous quarter (Q4 2023), and a -77.37% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $299K, a 595.35% increase from the previous quarter (Q3 2023), and a 415.52% increase year-over-year (Q4 2022). CLGN's quarterly revenue for Q3 2023 was $43K, a -99.58% decrease from the previous quarter (Q2 2023), and a -60.55% decrease year-over-year (Q3 2022).
What is CollPlant Bio’s revenue growth rate?
CollPlant Bio's revenue growth rate for the last 3 years (2021-2023) was -29.93%, and for the last 5 years (2019-2023) was 372.78%.